Skip to content
10-Q/A

Quarterly Report

THC Farmaceuticals, Inc.

0001515971-15-000304

← back to feed
Filed
Aug 19, 2015 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Aug 12, 2015 15M sh
Operating Cash Flow Q2 2015 · Mar 31, 2015 −$103.98K
Operating Cash Flow Q2 2015 · Mar 31, 2014 −$15.09K
Cash And Equivalents restated Q2 2015 · Mar 31, 2015 $586.28K
Cash And Equivalents Q2 2015 · Sep 30, 2014 $638
Cash And Equivalents Q2 2015 · Mar 31, 2014 $755
Cash And Equivalents Q2 2015 · Sep 30, 2013 $579
Stockholders Equity restated Q2 2015 · Mar 31, 2015 $1.05M
Stockholders Equity Q2 2015 · Sep 30, 2014 −$48.02K
Current Liabilities restated Q2 2015 · Mar 31, 2015 $653.24K
Current Liabilities restated Q2 2015 · Sep 30, 2014 $83.68K
Total Liabilities restated Q2 2015 · Mar 31, 2015 $653.51K
Total Liabilities restated Q2 2015 · Sep 30, 2014 $96.17K
Current Assets restated Q2 2015 · Mar 31, 2015 $599.38K
Current Assets Q2 2015 · Sep 30, 2014 $2.39K
Total Assets restated Q2 2015 · Mar 31, 2015 $1.7M
Total Assets restated Q2 2015 · Sep 30, 2014 $48.15K
Sga Expense restated Q2 2015 · Mar 31, 2015 $19.55K
Sga Expense restated Q2 2015 · Mar 31, 2015 $29.85K
Sga Expense Q2 2015 · Mar 31, 2014 $4.04K
Sga Expense Q2 2015 · Mar 31, 2014 $17.45K
Net Income restated Q2 2015 · Mar 31, 2015 −$19.8K
Net Income restated Q2 2015 · Mar 31, 2015 −$28.16K
Net Income Q2 2015 · Mar 31, 2014 −$3.63K
Net Income Q2 2015 · Mar 31, 2014 −$17.82K
Operating Income restated Q2 2015 · Mar 31, 2015 −$19.53K
Operating Income restated Q2 2015 · Mar 31, 2015 −$27.89K
Operating Income Q2 2015 · Mar 31, 2014 −$2.01K
Operating Income Q2 2015 · Mar 31, 2014 −$14.77K
Revenue restated Q2 2015 · Mar 31, 2015 $4.83K
Revenue restated Q2 2015 · Mar 31, 2015 $9.23K
Revenue Q2 2015 · Mar 31, 2014 $4.88K
Revenue Q2 2015 · Mar 31, 2014 $9.88K